These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9606814)

  • 1. Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma.
    Celli A; Que FG
    Semin Liver Dis; 1998; 18(2):177-85. PubMed ID: 9606814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights on the molecular and cell biology of human cholangiopathies.
    Alvaro D; Mancino MG
    Mol Aspects Med; 2008; 29(1-2):50-7. PubMed ID: 18230407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiologic and pathologic experimental models for studying cholangiocytes].
    Lee SO
    Korean J Hepatol; 2008 Jun; 14(2):139-49. PubMed ID: 18617761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of novel aspects of biliary pathophysiology.
    Marzioni M; Saccomanno S; Candelaresi C; Rychlicki C; Agostinelli L; Trozzi L; De Minicis S; Benedetti A
    Dig Liver Dis; 2010 Apr; 42(4):238-44. PubMed ID: 20167547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes.
    Hohenester S; Wenniger LM; Paulusma CC; van Vliet SJ; Jefferson DM; Elferink RP; Beuers U
    Hepatology; 2012 Jan; 55(1):173-83. PubMed ID: 21932391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
    Pinto C; Giordano DM; Maroni L; Marzioni M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathobiology of biliary epithelia.
    Roberts SK; Ludwig J; Larusso NF
    Gastroenterology; 1997 Jan; 112(1):269-79. PubMed ID: 8978368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathobiology of biliary epithelia.
    Alpini G; McGill JM; Larusso NF
    Hepatology; 2002 May; 35(5):1256-68. PubMed ID: 11981776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line.
    Harnois DM; Que FG; Celli A; LaRusso NF; Gores GJ
    Hepatology; 1997 Oct; 26(4):884-90. PubMed ID: 9328309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens maintain bile duct mass and reduce apoptosis after biliodigestive anastomosis in bile duct ligated rats.
    Svegliati-Baroni G; Ghiselli R; Marzioni M; Alvaro D; Mocchegiani F; Saccomanno S; Sisti V; Ugili L; Orlando F; Alpini G; Saba V; Benedetti A
    J Hepatol; 2006 Jun; 44(6):1158-66. PubMed ID: 16481066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical features of bile duct epithelial cells in normal and experimental liver conditions.
    Onori P; Franchitto A; Alvaro D; Gaudio E
    Ital J Anat Embryol; 2001; 106(2 Suppl 1):371-8. PubMed ID: 11729979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inflammatory and neoplastic cholangiopathies.].
    Alvaro D; Bragazzi MC; Ridola L
    Recenti Prog Med; 2018 Dec; 109(12):595-599. PubMed ID: 30667389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary brushing cytology.
    Selvaggi SM
    Cytopathology; 2004 Apr; 15(2):74-9. PubMed ID: 15056166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. erbB-2/neu transformed rat cholangiocytes recapitulate key cellular and molecular features of human bile duct cancer.
    Lai GH; Zhang Z; Shen XN; Ward DJ; Dewitt JL; Holt SE; Rozich RA; Hixson DC; Sirica AE
    Gastroenterology; 2005 Dec; 129(6):2047-57. PubMed ID: 16344070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells.
    Yokomuro S; Tsuji H; Lunz JG; Sakamoto T; Ezure T; Murase N; Demetris AJ
    Hepatology; 2000 Jul; 32(1):26-35. PubMed ID: 10869285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
    Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
    Bickenbach K; Galka E; Roggin KK
    Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and benign biliary tract diseases.
    Gradilone SA; O'Hara SP; Masyuk TV; Pisarello MJ; LaRusso NF
    Semin Liver Dis; 2015 Feb; 35(1):26-35. PubMed ID: 25632932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma.
    Chen RF; Li ZH; Zou SQ; Chen JS
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):71-4. PubMed ID: 15730924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
    Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
    J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.